News | Mammography | November 09, 2016

Study finds recall rates cut in half when mammograms compared to two or more prior examinations, compared to those interpreted without prior comparisons

mammography, comparison, prior examinations, UCSF study, American Journal of Roentgenology

November 9, 2016 — The recall rate of screening mammography is reduced when radiologists compare with more than one prior mammogram, a study published in the October 2016 issue of the American Journal of Roentgenology said.

"Our findings suggest that radiologists who make comparisons with more than one prior examination at screening mammography will have more true-positive outcomes and fewer false-positive outcomes," said study co-author Kimberly M. Ray, a radiologist with the Department of Radiology and Biomedical Imagining, University of California, San Francisco (UCSF). Ray is among several authors who published the paper, "Improving Screening Mammography Outcomes Through Comparison With Multiple Prior Mammograms."

"We have shown that the recall rate (percentage of cases with a potential abnormality that require additional imaging evaluation) for screening mammography decreases, whereas the positive predictive value of recall (PPV1) and the cancer detection rate increase when two or more prior examinations are used for comparison relative to comparison with a single prior examination," Ray said.

A large body of evidence indicates that screening mammography reduces the breast cancer mortality rate among women 40 years and older by approximately 20-40 percent. However, false-positives are frequently cited as the downside to mammographic screening because they cause patient anxiety, additional radiation exposure, biopsies and increased healthcare costs. The U.S. Preventive Services Task Force cited excessive false-positive results as a reason to avoid routine screening of women in their 40s and to recommend less frequent screening among older women.

"Consequently, although the reduced mortality rate associated with screening mammography arguably far outweighs the potential harms of the examination, a reduction in false-positive results should be a priority to ensure that support for and access to screening mammography are maintained," Ray said. "Because millions of women undergo screening mammography each year in the United States, even a small reduction in the recall rate may result in a widespread benefit."

Study authors retrospectively analyzed 46,288 consecutive screening mammograms performed at UCSF for 22,792 women. The examinations were divided into three groups: those interpreted without comparison with prior mammograms, those interpreted in comparison with one prior examination, and those interpreted in comparison with two or more prior examinations.

The recall rate for mammograms interpreted without comparison to prior examinations was 16.6 percent, whereas that for mammograms compared to one prior examination was 7.8 percent, and that for mammograms compared to two or more prior examinations was 6.3 percent.

For more information: www.ajronline.org


Related Content

News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | Mammography

Nov. 30, 2025 — At RSNA 2025, Siemens Healthineers will introduce new capabilities for its Mammomat B.brilliant ...

Time December 02, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Mammography

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced ...

Time November 29, 2025
arrow
News | Artificial Intelligence

Nov. 25, 2025 – Medical imaging AI company Avicenna.AI has announced a strategic partnership with Ferrum, an AI ...

Time November 25, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Breast Imaging

Nov. 17, 2025 — RadNet, Inc. and its wholly owned subsidiary, DeepHealth have announced results from the largest real ...

Time November 17, 2025
arrow
Subscribe Now